CD137 ligand signaling enhances myelopoiesis during infections

Qianqiao Tang, Dongsheng Jiang, Sylvie Alonso, Aakansha Pant, Julia M. Martínez Gómez, David Michael Kemeny, Lieping Chen, Herbert Schwarz

Research output: Contribution to journalArticle

Abstract

CD137 and its ligand are expressed in the BM, and conflicting data exist on the regulation of myelopoiesis by the CD137 receptor-ligand system. CD137-/- mice have increased numbers of myeloid cells in the BM, indicating an inhibitory influence of CD137 on myelopoiesis. However, CD137 also induces proliferation of hematopoietic progenitor cells and their myeloid differentiation, arguing for an enhancing effect. Here we hypothesized that this latter case represents the situation during infections since expression of CD137 is activation dependent and strongly enhanced during inflammation. Indeed, infections with Influenza, Bordetella pertussis, Mycobacterium bovis, Bacille Calmette-Guérin or Escherichia coli or i.p. injection of LPS led to increased numbers of CD137-expressing cells, especially of CD4+ T cells in the BM of mice. Coculture experiments confirmed that CD137 expression enables CD4+ T cells to induce proliferation and myeloid differentiation of BM and hematopoietic progenitor cells. CD137 also enhances myelopoiesis in vivo since the infection-induced increase in myeloid cell proliferation and total myeloid cell numbers in the BM were significantly lower in CD137-/- mice. This study reconciles earlier conflicting data by demonstrating that while CD137-CD137L interactions inhibit myelopoiesis during steady-state conditions they increase myelopoiesis during infection.

Original languageEnglish (US)
Pages (from-to)1555-1567
Number of pages13
JournalEuropean Journal of Immunology
Volume43
Issue number6
DOIs
StatePublished - Jun 2013
Externally publishedYes

Fingerprint

4-1BB Ligand
Myelopoiesis
Myeloid Cells
Infection
Hematopoietic Stem Cells
T-Lymphocytes
Bordetella pertussis
Mycobacterium bovis
Coculture Techniques
Human Influenza
Cell Count
Cell Proliferation
Escherichia coli
Inflammation
Injections

Keywords

  • BM
  • CD137
  • Infection
  • Myelopoiesis
  • T cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Tang, Q., Jiang, D., Alonso, S., Pant, A., Martínez Gómez, J. M., Kemeny, D. M., ... Schwarz, H. (2013). CD137 ligand signaling enhances myelopoiesis during infections. European Journal of Immunology, 43(6), 1555-1567. https://doi.org/10.1002/eji.201243071

CD137 ligand signaling enhances myelopoiesis during infections. / Tang, Qianqiao; Jiang, Dongsheng; Alonso, Sylvie; Pant, Aakansha; Martínez Gómez, Julia M.; Kemeny, David Michael; Chen, Lieping; Schwarz, Herbert.

In: European Journal of Immunology, Vol. 43, No. 6, 06.2013, p. 1555-1567.

Research output: Contribution to journalArticle

Tang, Q, Jiang, D, Alonso, S, Pant, A, Martínez Gómez, JM, Kemeny, DM, Chen, L & Schwarz, H 2013, 'CD137 ligand signaling enhances myelopoiesis during infections', European Journal of Immunology, vol. 43, no. 6, pp. 1555-1567. https://doi.org/10.1002/eji.201243071
Tang Q, Jiang D, Alonso S, Pant A, Martínez Gómez JM, Kemeny DM et al. CD137 ligand signaling enhances myelopoiesis during infections. European Journal of Immunology. 2013 Jun;43(6):1555-1567. https://doi.org/10.1002/eji.201243071
Tang, Qianqiao ; Jiang, Dongsheng ; Alonso, Sylvie ; Pant, Aakansha ; Martínez Gómez, Julia M. ; Kemeny, David Michael ; Chen, Lieping ; Schwarz, Herbert. / CD137 ligand signaling enhances myelopoiesis during infections. In: European Journal of Immunology. 2013 ; Vol. 43, No. 6. pp. 1555-1567.
@article{f52aef27d01e469db057f1345186b0ba,
title = "CD137 ligand signaling enhances myelopoiesis during infections",
abstract = "CD137 and its ligand are expressed in the BM, and conflicting data exist on the regulation of myelopoiesis by the CD137 receptor-ligand system. CD137-/- mice have increased numbers of myeloid cells in the BM, indicating an inhibitory influence of CD137 on myelopoiesis. However, CD137 also induces proliferation of hematopoietic progenitor cells and their myeloid differentiation, arguing for an enhancing effect. Here we hypothesized that this latter case represents the situation during infections since expression of CD137 is activation dependent and strongly enhanced during inflammation. Indeed, infections with Influenza, Bordetella pertussis, Mycobacterium bovis, Bacille Calmette-Gu{\'e}rin or Escherichia coli or i.p. injection of LPS led to increased numbers of CD137-expressing cells, especially of CD4+ T cells in the BM of mice. Coculture experiments confirmed that CD137 expression enables CD4+ T cells to induce proliferation and myeloid differentiation of BM and hematopoietic progenitor cells. CD137 also enhances myelopoiesis in vivo since the infection-induced increase in myeloid cell proliferation and total myeloid cell numbers in the BM were significantly lower in CD137-/- mice. This study reconciles earlier conflicting data by demonstrating that while CD137-CD137L interactions inhibit myelopoiesis during steady-state conditions they increase myelopoiesis during infection.",
keywords = "BM, CD137, Infection, Myelopoiesis, T cells",
author = "Qianqiao Tang and Dongsheng Jiang and Sylvie Alonso and Aakansha Pant and {Mart{\'i}nez G{\'o}mez}, {Julia M.} and Kemeny, {David Michael} and Lieping Chen and Herbert Schwarz",
year = "2013",
month = "6",
doi = "10.1002/eji.201243071",
language = "English (US)",
volume = "43",
pages = "1555--1567",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "6",

}

TY - JOUR

T1 - CD137 ligand signaling enhances myelopoiesis during infections

AU - Tang, Qianqiao

AU - Jiang, Dongsheng

AU - Alonso, Sylvie

AU - Pant, Aakansha

AU - Martínez Gómez, Julia M.

AU - Kemeny, David Michael

AU - Chen, Lieping

AU - Schwarz, Herbert

PY - 2013/6

Y1 - 2013/6

N2 - CD137 and its ligand are expressed in the BM, and conflicting data exist on the regulation of myelopoiesis by the CD137 receptor-ligand system. CD137-/- mice have increased numbers of myeloid cells in the BM, indicating an inhibitory influence of CD137 on myelopoiesis. However, CD137 also induces proliferation of hematopoietic progenitor cells and their myeloid differentiation, arguing for an enhancing effect. Here we hypothesized that this latter case represents the situation during infections since expression of CD137 is activation dependent and strongly enhanced during inflammation. Indeed, infections with Influenza, Bordetella pertussis, Mycobacterium bovis, Bacille Calmette-Guérin or Escherichia coli or i.p. injection of LPS led to increased numbers of CD137-expressing cells, especially of CD4+ T cells in the BM of mice. Coculture experiments confirmed that CD137 expression enables CD4+ T cells to induce proliferation and myeloid differentiation of BM and hematopoietic progenitor cells. CD137 also enhances myelopoiesis in vivo since the infection-induced increase in myeloid cell proliferation and total myeloid cell numbers in the BM were significantly lower in CD137-/- mice. This study reconciles earlier conflicting data by demonstrating that while CD137-CD137L interactions inhibit myelopoiesis during steady-state conditions they increase myelopoiesis during infection.

AB - CD137 and its ligand are expressed in the BM, and conflicting data exist on the regulation of myelopoiesis by the CD137 receptor-ligand system. CD137-/- mice have increased numbers of myeloid cells in the BM, indicating an inhibitory influence of CD137 on myelopoiesis. However, CD137 also induces proliferation of hematopoietic progenitor cells and their myeloid differentiation, arguing for an enhancing effect. Here we hypothesized that this latter case represents the situation during infections since expression of CD137 is activation dependent and strongly enhanced during inflammation. Indeed, infections with Influenza, Bordetella pertussis, Mycobacterium bovis, Bacille Calmette-Guérin or Escherichia coli or i.p. injection of LPS led to increased numbers of CD137-expressing cells, especially of CD4+ T cells in the BM of mice. Coculture experiments confirmed that CD137 expression enables CD4+ T cells to induce proliferation and myeloid differentiation of BM and hematopoietic progenitor cells. CD137 also enhances myelopoiesis in vivo since the infection-induced increase in myeloid cell proliferation and total myeloid cell numbers in the BM were significantly lower in CD137-/- mice. This study reconciles earlier conflicting data by demonstrating that while CD137-CD137L interactions inhibit myelopoiesis during steady-state conditions they increase myelopoiesis during infection.

KW - BM

KW - CD137

KW - Infection

KW - Myelopoiesis

KW - T cells

UR - http://www.scopus.com/inward/record.url?scp=84879488955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879488955&partnerID=8YFLogxK

U2 - 10.1002/eji.201243071

DO - 10.1002/eji.201243071

M3 - Article

C2 - 23519951

AN - SCOPUS:84879488955

VL - 43

SP - 1555

EP - 1567

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 6

ER -